首页> 外国专利> Lipid nanoparticle compositions for delivering antisense oligonucleotides

Lipid nanoparticle compositions for delivering antisense oligonucleotides

机译:用于递送反义寡核苷酸的脂质纳米颗粒组合物

摘要

Described is a lipid nanoparticle composition that includes a macromolecule conjugated to a polymer and a targeting agent. The composition can include a therapeutic agent. The therapeutic agent can be an antisense oligonucleotide (ASO). Exemplary ASOs are targeted to a portion of a nucleic acid encoding Akt-1, and which modulates the expression of Akt-1; or targeted to a portion of a nucleic acid encoding HIF-1, and which modulates the expression of HIF-1. Also described is a lipid nanoparticle composition that includes a macromolecule conjugated to a polymer and a therapeutic agent that is an ASO such as an ASO targeted to a portion of a nucleic acid encoding Akt-1, and which modulates the expression of Akt-1 or an ASO targeted to a portion of a nucleic acid encoding HIF-1, and which modulates the expression of HIF-1. Pharmaceutical formulations, methods of making the lipid nanoparticles, and methods of using the lipid nanoparticles, for example for treating cancers, are also disclosed.
机译:描述了一种脂质纳米颗粒组合物,其包括与聚合物结合的大分子和靶向剂。该组合物可以包含治疗剂。治疗剂可以是反义寡核苷酸(ASO)。示例性的ASO靶向于编码Akt-1的核酸的一部分,并调节Akt-1的表达。或靶向编码HIF-1的核酸的一部分,并调节HIF-1的表达。还描述了脂质纳米颗粒组合物,其包括缀合至聚合物的大分子和治疗剂,所述治疗剂是ASO,例如靶向编码Akt-1的核酸的一部分的ASO,并调节Akt-1或Akt-1的表达。靶向编码HIF-1的核酸的一部分并调节HIF-1表达的ASO。还公开了药物制剂,制备脂质纳米颗粒的方法和使用脂质纳米颗粒的方法,例如用于治疗癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号